Diagnostic radiology & CT course
Course dates
Wednesday 12 February - Friday 14 February 2025
Venue
The Royal Marsden Education and Conference Centre, Stewart’s Grove, London SW3 6JJ
Course overview
The course is organised by the Joint Department of Physics of The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research.
This course is designed to provide in-depth academic teaching of the scientific principles underpinning x-ray and CT imaging, including descriptions of the imaging components, system testing and performance, patient dosimetry, factors affecting image quality and examples of optimisation in healthcare settings.
The course is run over three days (Wednesday to Friday). Each day is designed to cover a particular theme. The first day covers the diagnostic radiology physics toolkit and the design of imaging systems; the second day focuses on performance and testing; the third day is dedicated to clinical applications, novel techniques and optimisation.
The course is primarily aimed at individuals who are undertaking formal training in medical physics. As well as being suitable for new entrants to the medical physics profession, it would also be of benefit to post-graduate students, post-doctoral research workers, physicist-managers, representatives of allied commercial organisations and anyone wishing to deepen or re-establish their understanding of the physics of medical imaging.
This is a CPD course approved by IPEM.
Provisional lecture list
- Design of the digital x-ray unit
- Design of the digital mammography unit
- The multi-slice CT scanner
- Patient dosimetry techniques
- Reconstruction in CT
- Digital image processing and presentation
- PACS, DICOM and displays
- Image quality assessment
- Performance of digital X-ray detectors
- X-ray quality control
- Quantitative image quality analysis
- Performance of CT imaging systems
- CT quality control
- Calculation of Effective Dose
- Digital system design and optimisation in clinical practice
- Developments in digital detector technology
- Advances in x-ray imaging techniques
- Advances in CT in radiology
- CT in radiotherapy
- CT in nuclear medicine
- CT optimisation in clinical practice
Registration & Course fees
All current course registration fees are given on our registration form.
The cost includes lunches and light refreshments. Electronic copies of the presentations and a certificate of attendance are provided.
You will be allocated a place on receipt of a completed registration form and a valid quoted payment reference/purchase order or completed bank transfer/online payment. We are unable to accept provisional bookings.
The number of participants is limited, so early booking is advised. Applications from outside the UK are welcome.
Closing date for registrations – Friday 24 January 2025.
Related documents
Provisional TimetableContacts
Course Organiser: Dr Jamie Dormand
For registration details and any other queries contact:
Course Administrator: Mrs Jessica Keegan

Latest ICR News

Blood cancer patients should be offered genetic testing to spot ‘double hit’ high-risk cases earlier
Offering extended genetic testing to patients with the blood cancer myeloma would help doctors spot those with the most aggressive forms of the disease so that their cancer can be targeted more effectively, say scientists from The Institute of Cancer Research, London.

Simple blood test could lead to smarter, kinder treatments for childhood cancers
Institute of Cancer Research scientists have developed a simple blood test that will help them better understand children’s cancers - and pave the way for new targeted and less toxic treatments.
-16-9.jpg?sfvrsn=b9495114_2)
Newly identified therapeutic target may lead to effective treatments for the most common and dangerous form of brain cancer
Scientists have shown for the first time that some of the most persistent cancer cells in glioblastoma, a common type of adult brain tumour, rely on a specific enzyme for survival and that inhibiting this enzyme leads to the death of the cells.

Scientists discover the ‘roadmap’ that aggressive cancer uses to spread around the body – identifying ways to block its escape
Scientists have discovered a new way to predict which tumours will become aggressive before they metastasise and spread around the body.